Key insights
- Morgan Stanley initiated coverage on Anthem (ANTM) with an Equalweight rating and a $30 price target. The analyst cited in-line Q1 results but noted improved forward KPIs and broad-based bookings strength. Anthem reiterated its annual guidance, and Morgan Stanley raised its 2026 adjusted EBITDA estimate by 1%. The neutral rating suggests a balanced outlook on Anthem's near-term performance, with limited direct influence on the broader US equity market.
Investing.com - Morgan Stanley initiated coverage on Anthem shares (NYSE:ANTM) with an Equalweight rating and a price target of $30.00.
Analyst Greg Parrish cited in-line first-quarter results but noted that forward key performance indicators improved and exceeded expectations.
The firm highlighted broad-based bookings strength with wins across key verticals, which demonstrate the advantages of Anthem’s integrated business model.
Anthem reiterated its guidance for the year. Morgan Stanley raised its adjusted EBITDA estimate for 2026 by 1%.
The $30 price target reflects Morgan Stanley’s neutral stance on the stock as it begins coverage.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.